Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05284448
What this trial is testing

Pentoxifylline in Treatment of Patients With Nonalcoholic Steatohepatitis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Al-Azhar University 50
Early research (Phase 1)Study completedNCT04483947
What this trial is testing

Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
AstraZeneca 74
Not applicableLooking for participantsNCT06138821
What this trial is testing

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Who this might be right for
ObesityLiver DiseasesLiver Fibrosis+16 more
Pichamol Jirapinyo, MD, MPH 132
Testing effectiveness (Phase 2)Study completedNCT01399645
What this trial is testing

Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisType 2 Diabetes
Centre hospitalier de l'Université de Montréal (CHUM) 35
Testing effectiveness (Phase 2)Ended earlyNCT03676231
What this trial is testing

Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Second Genome 9
Not applicableStudy completedNCT04180631
What this trial is testing

Quantitative US for Hepatic Steatosis

Who this might be right for
Hepatic Steatosis
Seoul National University Hospital 124
Testing effectiveness (Phase 2)Study completedNCT06140953
What this trial is testing

Benefits of Trimetazidine in MASLD Patients

Who this might be right for
Metabolic Associated Fatty Liver Disease
October 6 University 60
Testing effectiveness (Phase 2)Study completedNCT02927184
What this trial is testing

Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease

Who this might be right for
HyperlipidemiaNAFLD
Viking Therapeutics, Inc. 59
Testing effectiveness (Phase 2)Ended earlyNCT02855164
What this trial is testing

Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 350
Not applicableEnded earlyNCT03748511
What this trial is testing

Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver Disease

Who this might be right for
Patients With Fatty Liver Disease
HaEmek Medical Center, Israel 62
Very early researchNot Yet RecruitingNCT07198516
What this trial is testing

The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver:

Who this might be right for
NAFLDDiabete Type 2
Fujian Medical University Union Hospital 149
Not applicableStudy completedNCT04232293
What this trial is testing

Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2NAFLDNASH
Nantes University Hospital 722
Post-approval studies (Phase 4)Study completedNCT03796975
What this trial is testing

Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes MellitusNon-alcoholic Fatty Liver DiseaseEfficacy
Xijing Hospital 120
Not applicableUnknownNCT04653311
What this trial is testing

Evaluation of an Endoscopic Sutured Gastroplasty in Patients With NonAlcoholic Steatohepatitis (NASH) and Fibrosis.

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Erasme University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT02784444
What this trial is testing

Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Cirius Therapeutics, Inc. 392
Not applicableStudy completedNCT04049396
What this trial is testing

Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Lida Nejati 50
Testing effectiveness (Phase 2)UnknownNCT04772352
What this trial is testing

Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout

Who this might be right for
Nonalcoholic Fatty Liver Disease
Ningbo No. 1 Hospital 200
Not applicableStudy completedNCT03625362
What this trial is testing

Hydrogen-rich Water for Non-alchoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University of Novi Sad, Faculty of Sport and Physical Education 10
Not applicableActive Not RecruitingNCT04114682
What this trial is testing

Longitudinal Assessment of Multiple Organs in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Perspectum 135
Not applicableNot Yet RecruitingNCT07053709
What this trial is testing

Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Hyperuricemia and MAFLD
Assiut University 200
Next Page